Cargando…

Industry funding of patient and health consumer organisations: systematic review with meta-analysis

OBJECTIVE: To investigate pharmaceutical or medical device industry funding of patient groups. DESIGN: Systematic review with meta-analysis. DATA SOURCES: Ovid Medline, Embase, Web of Science, Scopus, and Google Scholar from inception to January 2018; reference lists of eligible studies and experts...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabbri, Alice, Parker, Lisa, Colombo, Cinzia, Mosconi, Paola, Barbara, Giussy, Frattaruolo, Maria Pina, Lau, Edith, Kroeger, Cynthia M, Lunny, Carole, Salzwedel, Douglas M, Mintzes, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190040/ https://www.ncbi.nlm.nih.gov/pubmed/31969320 http://dx.doi.org/10.1136/bmj.l6925

Ejemplares similares

Impact and use of reviews and ‘overviews of reviews’ to inform clinical practice guideline recommendations: protocol for a methods study
por: Lunny, Carole, et al.
Publicado: (2020)

Over half of clinical practice guidelines use non-systematic methods to inform recommendations: A methods study
por: Lunny, Carole, et al.
Publicado: (2021)

A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia
por: Fabbri, Alice, et al.
Publicado: (2017)

Self-management and psychological-sexological interventions in patients with endometriosis: strategies, outcomes, and integration into clinical care
por: Buggio, Laura, et al.
Publicado: (2017)

Vaginal rejuvenation: current perspectives
por: Barbara, Giussy, et al.
Publicado: (2017)

“Asset exchange”—interactions between patient groups and pharmaceutical industry: Australian qualitative study
por: Parker, Lisa, et al.
Publicado: (2019)

Exposing drug industry funding of UK patient organisations
Publicado: (2019)

Exposing drug industry funding of UK patient organisations
por: Ozieranski, Piotr, et al.
Publicado: (2019)

‘Lines in the sand’: an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders
por: Parker, Lisa, et al.
Publicado: (2021)

Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not?
por: Vercellini, Paolo, et al.
Publicado: (2023)

Industry funding of patient organisations in the UK: a retrospective study of commercial determinants, funding concentration and disease prevalence
por: Gentilini, Arianna, et al.
Publicado: (2023)

Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs
por: Mulinari, Shai, et al.
Publicado: (2020)

Patient Organizations’ Funding from Pharmaceutical Companies: Is Disclosure Clear, Complete and Accessible to the Public? An Italian Survey
por: Colombo, Cinzia, et al.
Publicado: (2012)

Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
por: Fabbri, Alice, et al.
Publicado: (2018)

Twelve Years' Experience with Direct-to-Consumer Advertising of Prescription Drugs in Canada: A Cautionary Tale
por: Mintzes, Barbara, et al.
Publicado: (2009)

Does a consumer training work? a follow-up survey of the PartecipaSalute training programs
por: Mosconi, Paola, et al.
Publicado: (2012)

Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and overactive bladder syndrome? An Australian cohort study
por: Mintzes, Barbara, et al.
Publicado: (2018)

Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
por: Pashley, Dylan, et al.
Publicado: (2022)

Synthetic biology in the view of European public funding organisations
por: Pei, Lei, et al.
Publicado: (2012)

Practices for Research Integrity Promotion in Research Performing Organisations and Research Funding Organisations: A Scoping Review
por: Ščepanović, Rea, et al.
Publicado: (2021)

Recent developments in the funding and organisation of the New Zealand health system
por: Ashton, Toni
Publicado: (2005)

Autonomy and Authority in Public Research Organisations: Structure and Funding Factors
por: Cruz-Castro, Laura, et al.
Publicado: (2018)

Non-communicable diseases: mapping research funding organisations, funding mechanisms and research practices in Italy and Germany
por: Stephani, Victor, et al.
Publicado: (2017)

Reaching consumers: How the tobacco industry uses email marketing
por: Brock, Betsy, et al.
Publicado: (2016)

Disease Mongering in Drug Promotion: Do Governments Have a Regulatory Role?
por: Mintzes, Barbara
Publicado: (2006)

Policing the promotion of prescription medicines – the new Medicines Australia Code of Conduct
por: Mintzes, Barbara
Publicado: (2021)

Risky business? Pharmaceutical industry sponsorship of health consumer groups
por: Bero, Lisa A, et al.
Publicado: (2021)

Pitfalls and Safeguards in Industry-Funded Research
por: Breault, Joseph L., et al.
Publicado: (2020)

Does type of funding affect reporting in network meta-analysis? A scoping review of network meta-analyses
por: Veroniki, Areti Angeliki, et al.
Publicado: (2023)

Advertising and disclosure of funding on patient organisation websites: a cross-sectional survey
por: Ball, Douglas E, et al.
Publicado: (2006)

Decision-making approaches used by UK and international health funding organisations for allocating research funds: A survey of current practice
por: Meadmore, Katie, et al.
Publicado: (2020)

Employers' organisations and industrial relations in Asia : record of proceedings of, and documents submitted to, a Regional Technical Seminar on Industrial Relations for Employers' Organisations in Asian Countries, Jakarta, November 1974.
Publicado: (1975)

Technological, healthcare and consumer funds efficiency: influence of COVID-19
por: Proença, Catarina Alexandra Neves, et al.
Publicado: (2023)

The fund industry: how your money is managed
por: Pozen, Robert C, et al.
Publicado: (2015)

“Drugs to avoid” to improve quality use of medicines: how is Australia faring?
por: Vitry, Agnes, et al.
Publicado: (2021)

Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study
por: Pokorny, Adrian M J, et al.
Publicado: (2023)

Press Releases Issued by Supplements Industry Organisations and Non-Industry Organisations in Response to Publication of Clinical Research Findings: A Case-Control Study
por: Wang, Michael T. M., et al.
Publicado: (2014)

Strengthening the incentives for responsible research practices in Australian health and medical research funding
por: Diong, Joanna, et al.
Publicado: (2021)

Medical, pharmacy and nursing students in the Baltic countries: interactions with the pharmaceutical and medical device industries
por: Salmane-Kulikovska, Ieva, et al.
Publicado: (2020)

Directing research funds to the right research projects: a review of criteria used by research organisations in Australia in prioritising health research projects for funding
por: Tuffaha, Haitham W, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6r934vdqro8ldm27rqro1eroqj